Mounjaro / Zepbound Understanding Compounded Tirzepatide Compared to Branded Options Tirzepatide is the active ingredient found in both Mounjaro (FDA-approved for type 2 diabetes) and Zepbound (FDA-approved for chronic weight management in certain adults)
Published on February 18th, 2024
Clinical manifestations of the patients were diverse, including aggravated edema, decreased appetite, fatigue, altered mental state, oliguria, shortness of breath, reduced urine output, nausea, vomiting, diarrhea, jaundice, abdominal pain, progressive edema, fever, chills, and constipation
Doll et al., 2019)
Mild injection site redness, temporary stomach cramping, and occasional dizziness also fall within expected adjustment responses
Its not a hormone